Ascend Laboratories, LLC recalls Dabigatran etexilate Capsules
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
- Products
-
- Dabigatran etexilate Capsules
- Company
- Ascend Laboratories, LLC
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 2,717 cartons
- About this recall
- Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7255-10.